Please enable JavaScript to continue using this application.

Compare $EQ vs $OKUR | Chartloom

Compare

$EQ vs $OKUR

Equillium Inc · Onkure Therapeutics Inc

Equillium Inc

OKUR

Onkure Therapeutics Inc

Compare $EQ vs $OKUR

Comparing Equillium Inc and Onkure Therapeutics Inc

EQEquillium Inc

OKUROnkure Therapeutics Inc

EQEquillium Inc

Market cap

$89M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-7.8%

52W performance

-4.1%

FCF yield

-22.5%

OKUROnkure Therapeutics Inc

Market cap

$97M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

71.59x

Rev growth (TTM)

—

YTD performance

-18.6%

52W performance

-20.7%

FCF yield

-49.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

OKUR

Detailed metrics comparison

Equillium Inc

OKUR

Onkure Therapeutics Inc

Market Cap

EQ$89M

OKUR$97M

Enterprise Value

EQ$32M

OKUR$-69M

Price

EQ$1.41

OKUR$2.41

P/E Ratio

EQN/A

OKURN/A

P/S Ratio

EQ2.18x

OKUR0.00x

EV/Sales

EQ0.78x

OKUR0.00x

EV/EBITDA

EQ0.00x

OKUR0.00x

P/B Ratio

EQ1.60x

OKUR0.60x

P/FCF Ratio

EQN/A

OKURN/A

EV/FCF

EQ-1.59x

OKUR1.44x

PEG Ratio

EQN/A

OKURN/A

Forward P/E (NTM)

EQN/A

OKURN/A

Forward P/S (NTM)

EQN/A

OKUR71.59x

Revenue (TTM)

EQ$0

OKUR$0

Revenue Growth (YoY)

EQN/A

OKURN/A

Forward Rev Growth

EQ0.0%

OKUR100.0%

Gross Margin (TTM)

EQ0.0%

OKUR0.0%

Operating Margin (TTM)

EQ0.0%

OKUR0.0%

EBITDA Margin (TTM)

EQ0.0%

OKUR0.0%

Net Margin (TTM)

EQ0.0%

OKUR0.0%

FCF Margin (TTM)

EQN/A

OKURN/A

Net Income (TTM)

EQ$-18M

OKUR$-59M

FCF (TTM)

EQ$-20M

OKUR$-48M

EPS (TTM)

EQ-$0.15

OKUR-$1.18

ROE (TTM)

EQ-6143.0%

OKUR-4902.0%

ROA (TTM)

EQ-5372.0%

OKUR-4577.0%

ROIC (TTM)

EQ-6143.0%

OKUR-4902.0%

Cash

EQ$57M

OKUR$167M

Debt

EQ$0

OKUR$0

Net Cash/Debt

EQ$57M

OKUR$167M

Current Ratio (TTM)

EQ23.40x

OKUR26.75x

Quick Ratio (TTM)

EQ23.07x

OKUR26.55x

Debt/Equity (TTM)

EQ0.00x

OKUR0.00x

Debt/Assets (TTM)

EQ0.0%

OKUR0.0%

Interest Coverage (TTM)

EQN/A

OKURN/A

Net Debt/EBITDA (TTM)

EQ0.00x

OKUR0.00x

Beta

EQ2.07

OKUR0.19

52W Performance

EQ-4.1%

OKUR-20.7%

YTD Performance

EQ-7.8%

OKUR-18.6%

% from 52W High

EQ-60.2%

OKUR-55.2%

% from 52W Low

EQ85.5%

OKUR13.1%

Asset Turnover (TTM)

EQ1.12x

OKUR0.00x

FCF Yield (TTM)

EQ-22.5%

OKUR-49.2%

Earnings Yield (TTM)

EQ-20.2%

OKUR-60.3%

Dividend Yield (TTM)

EQN/A

OKURN/A

Rule of 40

EQ0.0

OKUR0.0

EV/GP/RG

EQN/A

OKURN/A

Ticker research

View EQ research View OKUR research

Metric	EQ Equillium Inc	OKUR Onkure Therapeutics Inc
Market & Valuation
Market Cap	$89M	$97M
Enterprise Value	$32M	$-69M
Price	$1.41	$2.41
P/E Ratio	N/A	N/A
P/S Ratio	2.18x	0.00x
EV/Sales	0.78x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.60x	0.60x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.59x	1.44x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	71.59x
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	100.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-18M	$-59M
FCF (TTM)	$-20M	$-48M
EPS (TTM)	-$0.15	-$1.18
ROE (TTM)	-6143.0%	-4902.0%
ROA (TTM)	-5372.0%	-4577.0%
ROIC (TTM)	-6143.0%	-4902.0%
Financial Health
Cash	$57M	$167M
Debt	$0	$0
Net Cash/Debt	$57M	$167M
Current Ratio (TTM)	23.40x	26.75x
Quick Ratio (TTM)	23.07x	26.55x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.07	0.19
52W Performance	-4.1%	-20.7%
YTD Performance	-7.8%	-18.6%
% from 52W High	-60.2%	-55.2%
% from 52W Low	85.5%	13.1%
Efficiency & Yields
Asset Turnover (TTM)	1.12x	0.00x
FCF Yield (TTM)	-22.5%	-49.2%
Earnings Yield (TTM)	-20.2%	-60.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View EQ research	View OKUR research

Valuation

P/S Ratio

OKUR

0.00x

2.18x

EV/FCF

-1.59x

OKUR

1.44x

Growth & revenue

Forward Revenue Growth

OKUR

100.0%

0.0%

Profitability & performance

Gross Margin

0.0%

OKUR

0.0%

ROE

OKUR

-4902.0%

-6143.0%

FCF Yield %

-22.5%

OKUR

-49.2%

52-Week Performance

-4.1%

OKUR

-20.7%

Detailed metrics comparison

Equillium Inc

OKUR

Onkure Therapeutics Inc

Market Cap

EQ$89M

OKUR$97M

Enterprise Value

EQ$32M

OKUR$-69M

Price

EQ$1.41

OKUR$2.41

P/E Ratio

EQN/A

OKURN/A

P/S Ratio

EQ2.18x

OKUR0.00x

EV/Sales

EQ0.78x

OKUR0.00x

EV/EBITDA

EQ0.00x

OKUR0.00x

P/B Ratio

EQ1.60x

OKUR0.60x

P/FCF Ratio

EQN/A

OKURN/A

EV/FCF

EQ-1.59x

OKUR1.44x

PEG Ratio

EQN/A

OKURN/A

Forward P/E (NTM)

EQN/A

OKURN/A

Forward P/S (NTM)

EQN/A

OKUR71.59x

Revenue (TTM)

EQ$0

OKUR$0

Revenue Growth (YoY)

EQN/A

OKURN/A

Forward Rev Growth

EQ0.0%

OKUR100.0%

Gross Margin (TTM)

EQ0.0%

OKUR0.0%

Operating Margin (TTM)

EQ0.0%

OKUR0.0%

EBITDA Margin (TTM)

EQ0.0%

OKUR0.0%

Net Margin (TTM)

EQ0.0%

OKUR0.0%

FCF Margin (TTM)

EQN/A

OKURN/A

Net Income (TTM)

EQ$-18M

OKUR$-59M

FCF (TTM)

EQ$-20M

OKUR$-48M

EPS (TTM)

EQ-$0.15

OKUR-$1.18

ROE (TTM)

EQ-6143.0%

OKUR-4902.0%

ROA (TTM)

EQ-5372.0%

OKUR-4577.0%

ROIC (TTM)

EQ-6143.0%

OKUR-4902.0%

Cash

EQ$57M

OKUR$167M

Debt

EQ$0

OKUR$0

Net Cash/Debt

EQ$57M

OKUR$167M

Current Ratio (TTM)

EQ23.40x

OKUR26.75x

Quick Ratio (TTM)

EQ23.07x

OKUR26.55x

Debt/Equity (TTM)

EQ0.00x

OKUR0.00x

Debt/Assets (TTM)

EQ0.0%

OKUR0.0%

Interest Coverage (TTM)

EQN/A

OKURN/A

Net Debt/EBITDA (TTM)

EQ0.00x

OKUR0.00x

Beta

EQ2.07

OKUR0.19

52W Performance

EQ-4.1%

OKUR-20.7%

YTD Performance

EQ-7.8%

OKUR-18.6%

% from 52W High

EQ-60.2%

OKUR-55.2%

% from 52W Low

EQ85.5%

OKUR13.1%

Asset Turnover (TTM)

EQ1.12x

OKUR0.00x

FCF Yield (TTM)

EQ-22.5%

OKUR-49.2%

Earnings Yield (TTM)

EQ-20.2%

OKUR-60.3%

Dividend Yield (TTM)

EQN/A

OKURN/A

Rule of 40

EQ0.0

OKUR0.0

EV/GP/RG

EQN/A

OKURN/A

Ticker research

View EQ research View OKUR research

Metric	EQ Equillium Inc	OKUR Onkure Therapeutics Inc
Market & Valuation
Market Cap	$89M	$97M
Enterprise Value	$32M	$-69M
Price	$1.41	$2.41
P/E Ratio	N/A	N/A
P/S Ratio	2.18x	0.00x
EV/Sales	0.78x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.60x	0.60x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.59x	1.44x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	71.59x
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	100.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-18M	$-59M
FCF (TTM)	$-20M	$-48M
EPS (TTM)	-$0.15	-$1.18
ROE (TTM)	-6143.0%	-4902.0%
ROA (TTM)	-5372.0%	-4577.0%
ROIC (TTM)	-6143.0%	-4902.0%
Financial Health
Cash	$57M	$167M
Debt	$0	$0
Net Cash/Debt	$57M	$167M
Current Ratio (TTM)	23.40x	26.75x
Quick Ratio (TTM)	23.07x	26.55x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.07	0.19
52W Performance	-4.1%	-20.7%
YTD Performance	-7.8%	-18.6%
% from 52W High	-60.2%	-55.2%
% from 52W Low	85.5%	13.1%
Efficiency & Yields
Asset Turnover (TTM)	1.12x	0.00x
FCF Yield (TTM)	-22.5%	-49.2%
Earnings Yield (TTM)	-20.2%	-60.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View EQ research	View OKUR research